• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ann Intern Med . Characteristics, Outcomes, and Trends of Patients With COVID-19-Related Critical Illness at a Learning Health System in the United

tetano

Editor, Senior Moderator
Ann Intern Med


. 2021 Jan 19.
doi: 10.7326/M20-5327. Online ahead of print.
Characteristics, Outcomes, and Trends of Patients With COVID-19-Related Critical Illness at a Learning Health System in the United States


George L Anesi[SUP] 1 [/SUP], Juliane Jablonski[SUP] 1 [/SUP], Michael O Harhay[SUP] 1 [/SUP], Joshua H Atkins[SUP] 1 [/SUP], Jasmeet Bajaj[SUP] 1 [/SUP], Cameron Baston[SUP] 1 [/SUP], Patrick J Brennan[SUP] 1 [/SUP], Christina L Candeloro[SUP] 1 [/SUP], Lauren M Catalano[SUP] 1 [/SUP], Maurizio F Cereda[SUP] 1 [/SUP], John M Chandler[SUP] 1 [/SUP], Jason D Christie[SUP] 1 [/SUP], Tara Collins[SUP] 1 [/SUP], Katherine R Courtright[SUP] 1 [/SUP], Barry D Fuchs[SUP] 1 [/SUP], Emily Gordon[SUP] 1 [/SUP], John C Greenwood[SUP] 1 [/SUP], Steven Gudowski[SUP] 1 [/SUP], Asaf Hanish[SUP] 1 [/SUP], C William Hanson Iii[SUP] 1 [/SUP], Monica Heuer[SUP] 1 [/SUP], Paul Kinniry[SUP] 1 [/SUP], Zev Noah Kornfield[SUP] 1 [/SUP], Gregory B Kruse[SUP] 1 [/SUP], Meghan Lane-Fall[SUP] 1 [/SUP], Niels D Martin[SUP] 1 [/SUP], Mark E Mikkelsen[SUP] 1 [/SUP], Dan Negoianu[SUP] 1 [/SUP], Jose L Pascual[SUP] 1 [/SUP], Maulik B Patel[SUP] 1 [/SUP], Steven C Pugliese[SUP] 1 [/SUP], Zaffer A Qasim[SUP] 1 [/SUP], John P Reilly[SUP] 1 [/SUP], John Salmon[SUP] 1 [/SUP], William D Schweickert[SUP] 1 [/SUP], Michael J Scott[SUP] 1 [/SUP], Michael G S Shashaty[SUP] 1 [/SUP], Corinna P Sicoutris[SUP] 1 [/SUP], John K Wang[SUP] 1 [/SUP], Wei Wang[SUP] 1 [/SUP], Arshad A Wani[SUP] 1 [/SUP], Brian J Anderson[SUP] 1 [/SUP], Jacob T Gutsche[SUP] 1 [/SUP]



Affiliations

Abstract

Background: The coronavirus disease 2019 (COVID-19) pandemic continues to surge in the United States and globally.
Objective: To describe the epidemiology of COVID-19-related critical illness, including trends in outcomes and care delivery.
Design: Single-health system, multihospital retrospective cohort study.
Setting: 5 hospitals within the University of Pennsylvania Health System.
Patients: Adults with COVID-19-related critical illness who were admitted to an intensive care unit (ICU) with acute respiratory failure or shock during the initial surge of the pandemic.
Measurements: The primary exposure for outcomes and care delivery trend analyses was longitudinal time during the pandemic. The primary outcome was all-cause 28-day in-hospital mortality. Secondary outcomes were all-cause death at any time, receipt of mechanical ventilation (MV), and readmissions.
Results: Among 468 patients with COVID-19-related critical illness, 319 (68.2%) were treated with MV and 121 (25.9%) with vasopressors. Outcomes were notable for an all-cause 28-day in-hospital mortality rate of 29.9%, a median ICU stay of 8 days (interquartile range [IQR], 3 to 17 days), a median hospital stay of 13 days (IQR, 7 to 25 days), and an all-cause 30-day readmission rate (among nonhospice survivors) of 10.8%. Mortality decreased over time, from 43.5% (95% CI, 31.3% to 53.8%) to 19.2% (CI, 11.6% to 26.7%) between the first and last 15-day periods in the core adjusted model, whereas patient acuity and other factors did not change.
Limitation: Single-health system study; use of, or highly dynamic trends in, other clinical interventions were not evaluated, nor were complications.
Conclusion: Among patients with COVID-19-related critical illness admitted to ICUs of a learning health system in the United States, mortality seemed to decrease over time despite stable patient characteristics. Further studies are necessary to confirm this result and to investigate causal mechanisms.
Primary funding source: Agency for Healthcare Research and Quality.
 
Back
Top Bottom